These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4406296)

  • 41. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
    Senol G; Erbaycu A; Ozsöz A
    J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacodynamics of rifampicin--bacteriological and pharmacological action of rifampicin].
    Toyohara M
    Kekkaku; 1979 Dec; 54(12):576-8. PubMed ID: 392153
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-tuberculosis activity and drug interaction with nevirapine of inhalable lipid microspheres containing rifampicin in murine model.
    Disratthakit A; Doi N; Takenaga M; Ohta Y
    J Microencapsul; 2010; 27(4):365-71. PubMed ID: 20392161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results with rifampicin therapy of chronic tuberculosis].
    Böszörményi M
    Orv Hetil; 1973 Sep; 114(37):2215-21. PubMed ID: 4741358
    [No Abstract]   [Full Text] [Related]  

  • 45. Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis.
    Bishai WR; Graham NM; Harrington S; Page C; Moore-Rice K; Hooper N; Chaisson RE
    N Engl J Med; 1996 Jun; 334(24):1573-6. PubMed ID: 8628338
    [No Abstract]   [Full Text] [Related]  

  • 46. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 48. [Rifomycin in treatment of tuberculosis with polyresistant mycobacteria: clinical and laboratory observations].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):442-9. PubMed ID: 4984423
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 50. The pill and antibiotics.
    Harvey BD
    Br Dent J; 1993 Jul; 175(1):12. PubMed ID: 8334045
    [No Abstract]   [Full Text] [Related]  

  • 51. [Possible interference with the "pill" by antibiotic therapy].
    Marcucci M; Bandettini MV; Valenti G
    Attual Dent; 1990 Apr; 6(15):24-5. PubMed ID: 2206436
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacology--toxicology: introductory remarks on rifampicin.
    Freerksen E
    Acta Tuberc Pneumol Belg; 1969; 60(3):255-7. PubMed ID: 5371661
    [No Abstract]   [Full Text] [Related]  

  • 53. [Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs].
    Algeorge G; Sibilla S; Rudesco D
    Ann Pediatr (Paris); 1970 Oct; 17(10):674. PubMed ID: 5475418
    [No Abstract]   [Full Text] [Related]  

  • 54. [Rifampicin and positive microscopic findings in a negative Mycobacterium tuberculosis culture].
    Begović N; Drinković I; Popović I
    Plucne Bolesti Tuberk; 1972; 24(3):157-62. PubMed ID: 4632836
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rejection reaction and use of rifampicin in the treatment of tuberculosis in kidney transplantation].
    Farge D; Charpentier B; Simonneau G; Benoit G; Fries D
    Nephrologie; 1985; 6(2):53-7. PubMed ID: 3895010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 57. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].
    Chen HL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865
    [No Abstract]   [Full Text] [Related]  

  • 58. Experiences with rifampicin.
    Mary Aquinas Sister
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():137-9. PubMed ID: 4467982
    [No Abstract]   [Full Text] [Related]  

  • 59. The impact of rifampicin on the treatment of tuberculosis.
    Bayliss CG
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():140-3. PubMed ID: 4467983
    [No Abstract]   [Full Text] [Related]  

  • 60. [Rifampicin--a new antitubercular drug].
    Rózewska M
    Gruzlica; 1970 Feb; 38(2):171-7. PubMed ID: 5436933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.